The Effects of Chia on Overweight/Obese Women

May 8, 2018 updated by: Desiree Vera, California State Polytechnic University, Pomona

Effects of Chia Seed Consumption on Body Composition, Blood Pressure, Blood Glucose, Satiety, Diet Displacement, Joint Pain, Mood and Serotonin Levels in Young, Healthy, Overweight/Obese Females

The purpose of the study is to examine the effect of chia seed consumption on body composition, blood pressure, blood glucose, satiety, mood, joint pain, and dietary displacement in overweight and obese females (18-45years). It is hypothesized that consuming chia seeds will bring about a positive change in body composition (lower % body fat), satiety, mood, joint pain, and blood pressure, lower blood glucose levels, increased fiber and improved nutrient intake, in overweight/ obese females.

Study Overview

Detailed Description

Specific Objectives: 1. Determine if chia seed diet addition of 10% of Kcals (CHIA) positively changes body composition in young, healthy, overweight/obese people (Tanita scale). A) Determine if CHIA will decrease blood pressure (monitor). 2. Determine if CHIA will decrease blood glucose (draw) 3. Determine if CHIA increases satiety and improves diet (recordings). 4. Determine if CHIA will decrease joint pain (questionnaire). 5. Determine if CHIA will increase positive mood changes (questionnaires) and increase blood serotonin levels (draw).

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Pomona, California, United States, 91766
        • California State Polytechnic University, Pomona

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • are a female.
  • are between the ages of 18 and 45.
  • are not averse to consuming chia seeds on a regular basis (at least six weeks).
  • have not taken any medication for any chronic disease (heart, diabetes, cancer) for twelve weeks.
  • have not taken any steroid or hormone medication in the last eight weeks, excluding birth control pills...
  • do not consume excess amounts of nuts and seeds. - do not consume alcohol on a regular basis.
  • are not currently on a diet plan.
  • are not pregnant or plan to become pregnant.

Exclusion Criteria:

  • are a child, teenager, woman, or male younger than 18 or older than 45.
  • eat large quantities of chia seeds on a regular basis.
  • are taking any steroid or hormone medication (other than birth control pills). - are taking laxatives or fiber containing supplements on a regular basis.
  • are pregnant or become pregnant.
  • are currently on a diet plan.
  • have a known allergy to seeds.
  • consume excess amounts of seeds or nuts.
  • consume alcohol on a regular basis.
  • have a pacemaker or metal pins or plates in the body.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Chia Seeds
10% of a participants total kcal estimated needs given in chia seeds everyday for 8 weeks.
Chia seed added-10% of kcals and a no-chia control diet. 10% will be calculated using the following formula: Harris-Benedict equation multiplied by the activity factor of 1.2, 1.375, and 1.55 depending on each participant's activity level based on the information provided on the initial screening form.
No Intervention: Control
Habitual diet with avoidance of high fiber and high omega-3 fatty acid foods.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fasting plasma glucose
Time Frame: baseline
12-hour fasting plasma glucose levels will be assessed using a glucometer
baseline
Waist Circumference
Time Frame: baseline
waist circumference will be measured for each participant
baseline
Caloric intake
Time Frame: baseline
9, 3-day diet journals will be collected using a paper method
baseline
Serotonin
Time Frame: baseline
Urine serotonin levels will be assessed
baseline
Body Weight
Time Frame: Baseline
Tanita scale
Baseline
Body Mass Index
Time Frame: Baseline
Tanita sclae
Baseline
Body Fat Percentage
Time Frame: Baseline
Tanita scale
Baseline
Fasting plasma glucose
Time Frame: week 4
2-hour fasting plasma glucose levels will be assessed using a glucometer
week 4
Fasting plasma glucose
Time Frame: week 8
2-hour fasting plasma glucose levels will be assessed using a glucometer
week 8
Waist Circumference
Time Frame: week 4
waist circumference will be measured for each participant
week 4
Waist Circumference
Time Frame: week 8
waist will be measured for each participant
week 8
Caloric intake
Time Frame: week 4
9, 3-day diet journals will be collected using a paper method
week 4
Caloric intake
Time Frame: week 8
9, 3-day diet journals will be collected using a paper method
week 8
Serotonin
Time Frame: week 4
Urine serotonin levels will be assessed
week 4
Serotonin
Time Frame: week 8
Urine serotonin levels will be assessed
week 8
Body Weight
Time Frame: week 4
tanita scale
week 4
Body weight
Time Frame: week 8
tanita scale
week 8
Body mass index
Time Frame: week 4
tanita scale
week 4
body mass index
Time Frame: week 8
tanita scale
week 8
Body fat percentage
Time Frame: week 4
tanita scale
week 4
Body fat percentage
Time Frame: week 8
tanita scale
week 8
Hip Circumference
Time Frame: Baseline
Hip Circumference will be measured for each participant
Baseline
Hip Circumference
Time Frame: week 4
Hip Circumference will be measured for each participant
week 4
Hip Circumference
Time Frame: week 8
Hip Circumference will be measured for each participant
week 8

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood Pressure
Time Frame: baseline
Blood pressure will be taken using an automatic blood pressure machine
baseline
Blood Pressure
Time Frame: week 4
Blood pressure will be taken using an automatic blood pressure machine
week 4
Blood Pressure
Time Frame: week 8
Blood pressure will be taken using an automatic blood pressure machine
week 8
Joint Pain
Time Frame: baseline
Joint pain will be assessed using The WOMAC (Western Ontario and McMaster Universities) Index of Osteoarthritis
baseline
Joint Pain
Time Frame: week 4
Joint pain will be assessed using The WOMAC (Western Ontario and McMaster Universities) Index of Osteoarthritis
week 4
Joint Pain
Time Frame: week 8
Joint pain will be assessed using The WOMAC (Western Ontario and McMaster Universities) Index of Osteoarthritis
week 8
Mood
Time Frame: Baseline
Major Depression Inventory
Baseline
Mood
Time Frame: week 4
Major Depression Inventory
week 4
Mood
Time Frame: week 8
Major Depression Inventory
week 8
Physical Activity
Time Frame: Baseline
INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE (August 2002) SHORT LAST 7 DAYS SELF-ADMINISTERED FORMAT
Baseline
Physical Activity
Time Frame: week 4
INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE (August 2002) SHORT LAST 7 DAYS SELF-ADMINISTERED FORMAT
week 4
Physical Activity
Time Frame: week 8
INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE (August 2002) SHORT LAST 7 DAYS SELF-ADMINISTERED FORMAT
week 8
Sleep Quality
Time Frame: Baseline
Measuring sleep quality using the Pittsburgh Sleep Quality Index
Baseline
Sleep Quality
Time Frame: week 4
Measuring sleep quality using the Pittsburgh Sleep Quality Index
week 4
Sleep Quality
Time Frame: week 8
Measuring sleep quality using the Pittsburgh Sleep Quality Index
week 8
Fat mass
Time Frame: Baseline
using a tanita scale
Baseline
Fat mass
Time Frame: week 4
using a tanita scale
week 4
Fat mass
Time Frame: week 8
using a tanita scale
week 8
Fat Free Mass
Time Frame: Baseline
using a tanita scale
Baseline
Fat Free Mass
Time Frame: week 4
using a tanita scale
week 4
Fat Free Mass
Time Frame: week 8
using a tanita scale
week 8
Total body water
Time Frame: Baseline
using a tanita scale
Baseline
Total body water
Time Frame: week 4
using a tanita scale
week 4
Total body water
Time Frame: week 8
using a tanita scale
week 8
Macro nutrient intake
Time Frame: Baseline
3, 3-day diet journals will be collected using a paper method
Baseline
Macro nutrient intake
Time Frame: week 4
3, 3-day diet journals will be collected using a paper method
week 4
Macro nutrient intake
Time Frame: week 8
3, 3-day diet journals will be collected using a paper method
week 8
Micronutrient intake
Time Frame: Baseline
3, 3-day diet journals will be collected using a paper method
Baseline
Micronutrient intake
Time Frame: week 4
3, 3-day diet journals will be collected using a paper method
week 4
Micronutrient intake
Time Frame: week 8
3, 3-day diet journals will be collected using a paper method
week 8
Dietary intake Satiety
Time Frame: Baseline
3, 3-day diet journals will be collected using a paper method
Baseline
Dietary intake Satiety
Time Frame: week 4
3, 3-day diet journals will be collected using a paper method
week 4
Dietary intake Satiety
Time Frame: week 8
3, 3-day diet journals will be collected using a paper method
week 8
Dietary intake displacement
Time Frame: Baseline
3, 3-day diet journals will be collected using a paper method
Baseline
Dietary intake displacement
Time Frame: week 4
3, 3-day diet journals will be collected using a paper method
week 4
Dietary intake displacement
Time Frame: week 8
3, 3-day diet journals will be collected using a paper method
week 8

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Bonny Burns-Whitmore, DrPh, RD, California State Polytechnic University, Pomona

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 20, 2017

Primary Completion (Anticipated)

May 1, 2018

Study Completion (Anticipated)

August 1, 2018

Study Registration Dates

First Submitted

July 17, 2017

First Submitted That Met QC Criteria

July 27, 2017

First Posted (Actual)

July 31, 2017

Study Record Updates

Last Update Posted (Actual)

May 11, 2018

Last Update Submitted That Met QC Criteria

May 8, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRB-16-188

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Chia Seeds- Salvia Hispanica

Subscribe